Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma

NCT04172805 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma,Soft Tissue

Interventions

DRUG: anlotinib and toripalimab

Sponsor

Sun Yat-sen University